Healthcare & Life Sciences
Levicept
Levicept is a startup, most recent round Series A, 1 tracked investor.
activeseries-a
series-a
Stage
1
Investors
About Levicept
Levicept is a startup. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Levicept develops analgesic treatments aimed at alleviating chronic pain from osteoarthritis without the dependency risks of opiates or side effects associated with NSAIDs.
Explore Levicept's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.